| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 38 | 2024 | 1032 | 3.270 |
Why?
|
| Magnetic Resonance Imaging | 36 | 2024 | 1393 | 3.010 |
Why?
|
| Brain Mapping | 10 | 2024 | 208 | 2.550 |
Why?
|
| Brain Concussion | 8 | 2020 | 65 | 1.320 |
Why?
|
| Brain Diseases | 7 | 2024 | 39 | 1.260 |
Why?
|
| Football | 10 | 2020 | 82 | 1.200 |
Why?
|
| Image Interpretation, Computer-Assisted | 7 | 2018 | 115 | 1.140 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2017 | 260 | 1.060 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 66 | 1.030 |
Why?
|
| Spinal Fractures | 4 | 2012 | 45 | 0.940 |
Why?
|
| Radiology | 2 | 2024 | 46 | 0.930 |
Why?
|
| Brain Neoplasms | 9 | 2024 | 649 | 0.900 |
Why?
|
| Algorithms | 5 | 2017 | 561 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2018 | 1523 | 0.860 |
Why?
|
| Humans | 83 | 2024 | 34562 | 0.850 |
Why?
|
| Marijuana Abuse | 2 | 2019 | 20 | 0.820 |
Why?
|
| Male | 63 | 2024 | 20740 | 0.720 |
Why?
|
| Decision Making | 2 | 2019 | 203 | 0.700 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2024 | 988 | 0.700 |
Why?
|
| Nerve Net | 2 | 2014 | 141 | 0.680 |
Why?
|
| Radiosurgery | 5 | 2024 | 361 | 0.630 |
Why?
|
| Neuroradiography | 1 | 2019 | 2 | 0.620 |
Why?
|
| Cognition Disorders | 8 | 2018 | 390 | 0.610 |
Why?
|
| Sacrum | 3 | 2009 | 23 | 0.600 |
Why?
|
| Communication | 1 | 2020 | 144 | 0.600 |
Why?
|
| Reward | 2 | 2019 | 70 | 0.590 |
Why?
|
| Image Enhancement | 6 | 2014 | 74 | 0.570 |
Why?
|
| Adolescent | 23 | 2024 | 3805 | 0.550 |
Why?
|
| Rest | 2 | 2017 | 53 | 0.540 |
Why?
|
| Female | 48 | 2024 | 21532 | 0.540 |
Why?
|
| Cognition | 8 | 2018 | 576 | 0.540 |
Why?
|
| Cerebrovascular Disorders | 4 | 2020 | 55 | 0.530 |
Why?
|
| Atlases as Topic | 1 | 2016 | 10 | 0.480 |
Why?
|
| African Americans | 9 | 2018 | 1435 | 0.460 |
Why?
|
| Magnetoencephalography | 2 | 2014 | 15 | 0.440 |
Why?
|
| Cerebrovascular Circulation | 8 | 2023 | 104 | 0.440 |
Why?
|
| Craniocerebral Trauma | 4 | 2019 | 59 | 0.440 |
Why?
|
| Adult | 26 | 2024 | 10030 | 0.440 |
Why?
|
| Spin Labels | 9 | 2023 | 27 | 0.430 |
Why?
|
| Cerebrum | 1 | 2014 | 6 | 0.420 |
Why?
|
| Alzheimer Disease | 4 | 2019 | 295 | 0.400 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 3 | 2019 | 28 | 0.380 |
Why?
|
| Middle Aged | 30 | 2024 | 12726 | 0.370 |
Why?
|
| Bone Cements | 2 | 2012 | 13 | 0.360 |
Why?
|
| Young Adult | 14 | 2024 | 2831 | 0.360 |
Why?
|
| Polymethyl Methacrylate | 2 | 2012 | 13 | 0.350 |
Why?
|
| Aged | 25 | 2024 | 11022 | 0.350 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1129 | 0.350 |
Why?
|
| Child | 18 | 2024 | 2614 | 0.350 |
Why?
|
| Animals | 20 | 2023 | 8579 | 0.350 |
Why?
|
| Glucose | 5 | 2003 | 194 | 0.330 |
Why?
|
| Athletes | 4 | 2019 | 72 | 0.320 |
Why?
|
| Models, Neurological | 1 | 2011 | 145 | 0.310 |
Why?
|
| Brain Injuries | 3 | 2015 | 94 | 0.310 |
Why?
|
| Head Injuries, Closed | 3 | 2019 | 16 | 0.300 |
Why?
|
| Positron-Emission Tomography | 4 | 2020 | 177 | 0.300 |
Why?
|
| Microtubules | 2 | 2020 | 22 | 0.290 |
Why?
|
| Mutation | 4 | 2024 | 532 | 0.290 |
Why?
|
| Head | 2 | 2020 | 61 | 0.290 |
Why?
|
| Vitronectin | 1 | 2008 | 6 | 0.290 |
Why?
|
| Drug Implants | 1 | 2008 | 11 | 0.290 |
Why?
|
| Hypercapnia | 2 | 2023 | 5 | 0.280 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 302 | 0.280 |
Why?
|
| Embolization, Therapeutic | 1 | 2008 | 87 | 0.270 |
Why?
|
| Laminectomy | 1 | 2007 | 17 | 0.260 |
Why?
|
| Emotions | 2 | 2018 | 60 | 0.260 |
Why?
|
| Back Pain | 1 | 2007 | 32 | 0.260 |
Why?
|
| Telemetry | 5 | 2020 | 30 | 0.260 |
Why?
|
| Epilepsy | 2 | 2024 | 86 | 0.260 |
Why?
|
| Models, Biological | 2 | 2019 | 432 | 0.250 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2013 | 79 | 0.250 |
Why?
|
| Neuropsychological Tests | 8 | 2018 | 372 | 0.250 |
Why?
|
| Retrospective Studies | 13 | 2024 | 3825 | 0.250 |
Why?
|
| Head Protective Devices | 5 | 2018 | 50 | 0.240 |
Why?
|
| Sensitivity and Specificity | 6 | 2024 | 614 | 0.240 |
Why?
|
| Reproducibility of Results | 6 | 2024 | 823 | 0.230 |
Why?
|
| Acceleration | 4 | 2020 | 75 | 0.230 |
Why?
|
| Aged, 80 and over | 10 | 2024 | 4157 | 0.230 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2016 | 35 | 0.220 |
Why?
|
| Gambling | 1 | 2004 | 6 | 0.220 |
Why?
|
| Carbon Dioxide | 2 | 2023 | 40 | 0.220 |
Why?
|
| Carbon Radioisotopes | 3 | 2020 | 24 | 0.210 |
Why?
|
| Hippocampus | 2 | 2018 | 225 | 0.200 |
Why?
|
| Finite Element Analysis | 2 | 2019 | 89 | 0.200 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2013 | 22 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 120 | 0.200 |
Why?
|
| Temporal Bone | 2 | 2013 | 22 | 0.200 |
Why?
|
| Quinazolines | 2 | 2020 | 40 | 0.190 |
Why?
|
| Sex Characteristics | 2 | 2014 | 182 | 0.190 |
Why?
|
| Radiation Injuries | 1 | 2023 | 87 | 0.190 |
Why?
|
| Arteries | 1 | 2023 | 83 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 117 | 0.190 |
Why?
|
| Rats | 9 | 2018 | 1946 | 0.190 |
Why?
|
| Albuminuria | 4 | 2017 | 181 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 34 | 0.180 |
Why?
|
| Databases, Factual | 3 | 2024 | 380 | 0.180 |
Why?
|
| Treatment Outcome | 5 | 2023 | 3623 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2008 | 923 | 0.180 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 205 | 0.180 |
Why?
|
| Radiopharmaceuticals | 2 | 2020 | 103 | 0.170 |
Why?
|
| Atrophy | 3 | 2016 | 51 | 0.170 |
Why?
|
| Analysis of Variance | 4 | 2013 | 508 | 0.170 |
Why?
|
| Prefrontal Cortex | 2 | 2018 | 90 | 0.160 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2020 | 38 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 455 | 0.160 |
Why?
|
| Radiation Dosage | 1 | 2020 | 96 | 0.160 |
Why?
|
| European Continental Ancestry Group | 4 | 2018 | 1176 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 96 | 0.160 |
Why?
|
| Whole-Body Irradiation | 1 | 2020 | 59 | 0.160 |
Why?
|
| Diabetes Complications | 3 | 2018 | 189 | 0.160 |
Why?
|
| Athletic Performance | 1 | 2020 | 14 | 0.160 |
Why?
|
| Organ Size | 5 | 2018 | 236 | 0.160 |
Why?
|
| Hemiplegia | 1 | 2019 | 12 | 0.150 |
Why?
|
| Seasons | 2 | 2018 | 94 | 0.150 |
Why?
|
| Antibodies, Bispecific | 1 | 2019 | 7 | 0.150 |
Why?
|
| Spine | 1 | 2019 | 47 | 0.150 |
Why?
|
| Amyloid | 1 | 2019 | 17 | 0.150 |
Why?
|
| Peptide Fragments | 2 | 2019 | 430 | 0.150 |
Why?
|
| Diet, Mediterranean | 1 | 2019 | 32 | 0.150 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 95 | 0.150 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 16 | 0.150 |
Why?
|
| Age of Onset | 1 | 2019 | 95 | 0.150 |
Why?
|
| Stress, Psychological | 2 | 2018 | 233 | 0.150 |
Why?
|
| Salvage Therapy | 1 | 2020 | 138 | 0.150 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 29 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2016 | 56 | 0.140 |
Why?
|
| Parkinsonian Disorders | 2 | 2019 | 11 | 0.140 |
Why?
|
| Body Weight | 2 | 2018 | 343 | 0.140 |
Why?
|
| Models, Anatomic | 1 | 2019 | 39 | 0.140 |
Why?
|
| Hyperemia | 2 | 2008 | 11 | 0.140 |
Why?
|
| Risk | 4 | 2020 | 325 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 104 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 35 | 0.140 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 57 | 0.140 |
Why?
|
| Dystonic Disorders | 2 | 2016 | 14 | 0.140 |
Why?
|
| Mental Recall | 1 | 2018 | 52 | 0.140 |
Why?
|
| Child, Preschool | 7 | 2023 | 1355 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 5 | 2017 | 315 | 0.130 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 68 | 0.130 |
Why?
|
| Neural Pathways | 2 | 2016 | 116 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 116 | 0.130 |
Why?
|
| Athletic Injuries | 1 | 2018 | 97 | 0.130 |
Why?
|
| Calcium | 1 | 2019 | 343 | 0.130 |
Why?
|
| Macaca mulatta | 3 | 2023 | 355 | 0.130 |
Why?
|
| Students | 1 | 2018 | 178 | 0.130 |
Why?
|
| Linear Models | 5 | 2018 | 465 | 0.130 |
Why?
|
| Nootropic Agents | 1 | 2017 | 14 | 0.130 |
Why?
|
| Cerebral Arteries | 2 | 2013 | 23 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 91 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2018 | 417 | 0.120 |
Why?
|
| Ataxia | 1 | 2016 | 8 | 0.120 |
Why?
|
| Prognosis | 4 | 2024 | 1606 | 0.120 |
Why?
|
| Neoplasms | 2 | 2020 | 793 | 0.120 |
Why?
|
| Primates | 1 | 2016 | 130 | 0.110 |
Why?
|
| Frontal Sinusitis | 1 | 2015 | 4 | 0.110 |
Why?
|
| Epidural Abscess | 1 | 2015 | 5 | 0.110 |
Why?
|
| Fever | 1 | 2015 | 63 | 0.110 |
Why?
|
| Skull Fractures | 2 | 2012 | 18 | 0.110 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2013 | 21 | 0.110 |
Why?
|
| Skull | 1 | 2014 | 49 | 0.110 |
Why?
|
| Siblings | 1 | 2014 | 24 | 0.110 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2014 | 1 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2016 | 201 | 0.110 |
Why?
|
| Diagnostic Imaging | 3 | 2023 | 103 | 0.110 |
Why?
|
| Equipment Design | 2 | 2018 | 192 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 257 | 0.100 |
Why?
|
| Ear, Inner | 1 | 2013 | 9 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2016 | 249 | 0.100 |
Why?
|
| Leukoaraiosis | 1 | 2013 | 6 | 0.100 |
Why?
|
| Infant | 6 | 2013 | 1123 | 0.100 |
Why?
|
| Ocular Motility Disorders | 1 | 2013 | 3 | 0.100 |
Why?
|
| Ear | 1 | 2013 | 18 | 0.100 |
Why?
|
| Pattern Recognition, Automated | 1 | 2013 | 38 | 0.100 |
Why?
|
| Body Temperature | 2 | 2003 | 23 | 0.100 |
Why?
|
| Hematoma, Subdural | 1 | 2012 | 12 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2019 | 585 | 0.100 |
Why?
|
| Receptors, Drug | 2 | 2003 | 21 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 228 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 137 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 806 | 0.090 |
Why?
|
| Quality of Life | 1 | 2018 | 1032 | 0.090 |
Why?
|
| Calcinosis | 1 | 2013 | 150 | 0.090 |
Why?
|
| United States | 5 | 2024 | 4278 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 2012 | 44 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 34 | 0.090 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 58 | 0.090 |
Why?
|
| Atherosclerosis | 2 | 2015 | 837 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 431 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 1607 | 0.090 |
Why?
|
| Maxillary Sinus | 1 | 2011 | 7 | 0.080 |
Why?
|
| Facial Bones | 1 | 2011 | 9 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2012 | 116 | 0.080 |
Why?
|
| Immunotherapy | 2 | 2024 | 96 | 0.080 |
Why?
|
| Facial Injuries | 1 | 2011 | 12 | 0.080 |
Why?
|
| Disease Progression | 3 | 2024 | 634 | 0.080 |
Why?
|
| Kidney Function Tests | 3 | 2016 | 107 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 265 | 0.080 |
Why?
|
| Motor Activity | 2 | 2003 | 356 | 0.080 |
Why?
|
| Accidents, Traffic | 1 | 2012 | 210 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 548 | 0.080 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 30 | 0.080 |
Why?
|
| Perfusion Imaging | 1 | 2009 | 8 | 0.070 |
Why?
|
| Tuberous Sclerosis | 1 | 2009 | 7 | 0.070 |
Why?
|
| Age Factors | 3 | 2018 | 1262 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 47 | 0.070 |
Why?
|
| Platinum | 1 | 2008 | 21 | 0.070 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2008 | 19 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2018 | 1910 | 0.070 |
Why?
|
| Hypoxia, Brain | 1 | 2008 | 4 | 0.070 |
Why?
|
| Deoxyglucose | 3 | 2003 | 16 | 0.070 |
Why?
|
| Prosthesis Design | 1 | 2008 | 116 | 0.070 |
Why?
|
| Materials Testing | 1 | 2008 | 93 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2008 | 71 | 0.070 |
Why?
|
| Pain Measurement | 2 | 2007 | 385 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 1010 | 0.070 |
Why?
|
| Heterozygote | 2 | 2019 | 66 | 0.070 |
Why?
|
| Dystonia | 2 | 2019 | 12 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2008 | 129 | 0.070 |
Why?
|
| Infusions, Intraosseous | 1 | 2007 | 1 | 0.070 |
Why?
|
| Occipital Lobe | 2 | 2017 | 5 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 590 | 0.060 |
Why?
|
| Cadaver | 1 | 2007 | 170 | 0.060 |
Why?
|
| Blood Flow Velocity | 3 | 2013 | 87 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2019 | 633 | 0.060 |
Why?
|
| Memory | 2 | 2019 | 216 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2007 | 256 | 0.060 |
Why?
|
| Ethanol | 2 | 1998 | 199 | 0.060 |
Why?
|
| Pyrazoles | 2 | 2003 | 81 | 0.060 |
Why?
|
| Creatinine | 2 | 2017 | 206 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2015 | 529 | 0.060 |
Why?
|
| Piperidines | 2 | 2003 | 141 | 0.060 |
Why?
|
| Risk Factors | 3 | 2020 | 4137 | 0.050 |
Why?
|
| Time | 1 | 2004 | 29 | 0.050 |
Why?
|
| Hypertension | 3 | 2017 | 1024 | 0.050 |
Why?
|
| Time Factors | 4 | 2003 | 2353 | 0.050 |
Why?
|
| Depression | 2 | 2018 | 458 | 0.050 |
Why?
|
| Radiography | 2 | 2015 | 397 | 0.050 |
Why?
|
| Genomics | 1 | 2024 | 94 | 0.050 |
Why?
|
| Language | 1 | 2024 | 45 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 55 | 0.050 |
Why?
|
| Head Movements | 2 | 2013 | 15 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2024 | 168 | 0.050 |
Why?
|
| Locomotion | 1 | 2003 | 37 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 755 | 0.050 |
Why?
|
| Rotation | 2 | 2013 | 54 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 85 | 0.050 |
Why?
|
| Mice | 2 | 2019 | 2720 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 51 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2002 | 16 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 306 | 0.040 |
Why?
|
| Running | 1 | 2020 | 21 | 0.040 |
Why?
|
| Cocaine | 1 | 2003 | 355 | 0.040 |
Why?
|
| Ketone Bodies | 1 | 2019 | 8 | 0.040 |
Why?
|
| Mental Disorders | 2 | 2013 | 127 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 100 | 0.040 |
Why?
|
| HMGA2 Protein | 1 | 2019 | 12 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2019 | 30 | 0.040 |
Why?
|
| Movement Disorders | 1 | 2019 | 29 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 66 | 0.040 |
Why?
|
| China | 1 | 2018 | 58 | 0.040 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 1209 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 98 | 0.040 |
Why?
|
| Video Recording | 1 | 2018 | 64 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 120 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 98 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 176 | 0.040 |
Why?
|
| Sucrose | 1 | 1998 | 20 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 549 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 476 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 97 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 341 | 0.030 |
Why?
|
| Neurotic Disorders | 1 | 2017 | 2 | 0.030 |
Why?
|
| Forecasting | 1 | 2018 | 153 | 0.030 |
Why?
|
| Personality | 1 | 2017 | 15 | 0.030 |
Why?
|
| Universities | 1 | 2018 | 152 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 600 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 928 | 0.030 |
Why?
|
| Autoradiography | 3 | 2003 | 55 | 0.030 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 21 | 0.030 |
Why?
|
| Anxiety | 1 | 2018 | 206 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 781 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 232 | 0.030 |
Why?
|
| tau Proteins | 1 | 2017 | 40 | 0.030 |
Why?
|
| Alcoholism | 1 | 1998 | 104 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 185 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 149 | 0.030 |
Why?
|
| Cerebellum | 1 | 2016 | 27 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 39 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 80 | 0.030 |
Why?
|
| Schools | 1 | 2016 | 67 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 703 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 267 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 597 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1290 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 130 | 0.030 |
Why?
|
| Forehead | 1 | 2015 | 13 | 0.030 |
Why?
|
| Edema | 1 | 2015 | 31 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1998 | 261 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 149 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 744 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 23 | 0.030 |
Why?
|
| Stroop Test | 1 | 2014 | 5 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 24 | 0.030 |
Why?
|
| Albumins | 1 | 2014 | 47 | 0.030 |
Why?
|
| Neck | 1 | 2014 | 33 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2367 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 88 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 257 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 565 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2013 | 33 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2014 | 124 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 542 | 0.020 |
Why?
|
| Smoking | 1 | 2017 | 544 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 230 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 110 | 0.020 |
Why?
|
| Nitrous Oxide | 1 | 2013 | 4 | 0.020 |
Why?
|
| Body Water | 1 | 2013 | 11 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2014 | 150 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2013 | 10 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 1508 | 0.020 |
Why?
|
| Brain Death | 1 | 2013 | 27 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 233 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 28 | 0.020 |
Why?
|
| Sample Size | 1 | 2012 | 40 | 0.020 |
Why?
|
| Air Bags | 1 | 2012 | 16 | 0.020 |
Why?
|
| Occipital Bone | 1 | 2012 | 18 | 0.020 |
Why?
|
| Receptors, Cannabinoid | 2 | 2003 | 35 | 0.020 |
Why?
|
| Seizures | 1 | 2013 | 67 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2012 | 113 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2013 | 180 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 657 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 101 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 901 | 0.020 |
Why?
|
| Glioma | 1 | 2013 | 138 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 803 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 708 | 0.020 |
Why?
|
| Dementia | 1 | 2013 | 253 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 441 | 0.020 |
Why?
|
| Self Administration | 2 | 2003 | 386 | 0.020 |
Why?
|
| Hamartoma | 1 | 2009 | 11 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2009 | 29 | 0.020 |
Why?
|
| Contrast Media | 1 | 2009 | 149 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 12 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2008 | 33 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2008 | 16 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 95 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2008 | 43 | 0.020 |
Why?
|
| Homeostasis | 1 | 2008 | 137 | 0.020 |
Why?
|
| Glycolysis | 1 | 2003 | 21 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2003 | 41 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 2003 | 125 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2003 | 168 | 0.010 |
Why?
|
| Neocortex | 1 | 1998 | 5 | 0.010 |
Why?
|
| Limbic System | 1 | 1998 | 16 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1998 | 74 | 0.010 |
Why?
|
| Injections | 1 | 1998 | 76 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 113 | 0.010 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 1998 | 3 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1998 | 213 | 0.010 |
Why?
|